Report overview
The global Adipose Tissue Derived Stem Cell market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Source of Human Fat Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Adipose Tissue Derived Stem Cell include Lonza, ThermoFisher Scientific Inc, Celprogen, Inc, iXCells Biotechnologies, Merck KGaA, Lifeline Cell Technology, AlloCure, Inc, Antria, Inc and Celgene Corporation, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
The stem cells from adipose tissue have a variety of uses, including research on stem cell differentiation, cell therapy, tissue engineering, and the creation of induced pluripotent stem cell lineages. These are rich in multipotent stem cells, adipocytes, osteocytes, chondrocytes, and other cell types can all be differentiated into adipocytes, osteocytes, and other cell types in vitro.
This report aims to provide a comprehensive presentation of the global market for Adipose Tissue Derived Stem Cell, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adipose Tissue Derived Stem Cell. This report contains market size and forecasts of Adipose Tissue Derived Stem Cell in global, including the following market information:
Global Adipose Tissue Derived Stem Cell Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Adipose Tissue Derived Stem Cell Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Adipose Tissue Derived Stem Cell companies in 2023 (%)
We surveyed the Adipose Tissue Derived Stem Cell manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Adipose Tissue Derived Stem Cell Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Adipose Tissue Derived Stem Cell Market Segment Percentages, by Type, 2023 (%)
Source of Human Fat
Source of Animal Fat
Global Adipose Tissue Derived Stem Cell Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Adipose Tissue Derived Stem Cell Market Segment Percentages, by Application, 2023 (%)
Regenerative Medicine
Plastic Surgery
Other
Global Adipose Tissue Derived Stem Cell Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Adipose Tissue Derived Stem Cell Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Adipose Tissue Derived Stem Cell revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Adipose Tissue Derived Stem Cell revenues share in global market, 2023 (%)
Key companies Adipose Tissue Derived Stem Cell sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Adipose Tissue Derived Stem Cell sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lonza
ThermoFisher Scientific Inc
Celprogen, Inc
iXCells Biotechnologies
Merck KGaA
Lifeline Cell Technology
AlloCure, Inc
Antria, Inc
Celgene Corporation
Cellleris SA
Corestem, Inc
Cytori Therapeutics, Inc
Intrexon, Inc
Mesoblast Ltd
Pluristem Therapeutics, Inc
Tissue Genesis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Adipose Tissue Derived Stem Cell, market overview.
Chapter 2: Global Adipose Tissue Derived Stem Cell market size in revenue and volume.
Chapter 3: Detailed analysis of Adipose Tissue Derived Stem Cell manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Adipose Tissue Derived Stem Cell in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Adipose Tissue Derived Stem Cell capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
